Dr. Grous is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
736 Cambridge St
Brighton, MA 02135- Is this information wrong?
Education & Training
- Tufts University School of MedicineClass of 1981
Publications & Presentations
PubMed
- 399 citationsSafety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic CancerDung T. Le, Andrea Wang-Gillam, Vincent J. Picozzi, Tim F. Greten, Todd S. Crocenzi, Gregory M. Springett, Michael A. Morse, Herbert J. Zeh, Deirdre Jill Cohen, Robert...> ;Journal of Clinical Oncology. 2015 Apr 20
- Phase III study of sustained release granisetron (APF530) compared to palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV).Grous JJ, Riegel E, Gabrail N, Charu V, Arevalo-Araujo R, Yanagihara R, Nguyen A, Robertson P, Cooper B, O'Boyle E, Barr J> ;J. Clin. Oncol.. 2009-05-20
- GCS-100, a galectin-3 antagonist, in refractory solid tumors: A phase I study.Grous JJ, Redfern CH, Mahadevan D, Schindler J> ;J. Clin. Oncol.. 2006-06-20
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: